ChartMill assigns a Buy % Consensus number of 84% to KRYS. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-22 | B of A Securities | Maintains | Buy -> Buy |
| 2026-01-12 | Citigroup | Maintains | Buy -> Buy |
| 2026-01-09 | TD Cowen | Maintains | Buy -> Buy |
| 2026-01-09 | Citigroup | Maintains | Buy -> Buy |
| 2026-01-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2026-01-06 | Citigroup | Upgrade | Neutral -> Buy |
| 2025-11-04 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-11-04 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-10-17 | B of A Securities | Maintains | Buy -> Buy |
| 2025-09-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-22 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-05 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-05 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-07-25 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-07-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-22 | B of A Securities | Maintains | Buy -> Buy |
| 2025-07-10 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-07-01 | Clear Street | Initiate | Buy |
| 2025-06-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-16 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-05-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-07 | Guggenheim | Maintains | Buy -> Buy |
| 2025-05-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-05 | Jefferies | Initiate | Buy |
| 2025-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-20 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-02-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
18 analysts have analysed KRYS and the average price target is 269.93 USD. This implies a price decrease of -2.91% is expected in the next year compared to the current price of 278.015.
The consensus rating for KRYSTAL BIOTECH INC (KRYS) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering KRYSTAL BIOTECH INC (KRYS) is 18.